Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma
Authors:
- P.N.M. ChengPCP.N.M. Cheng
- Y.C. LeungYLY.C. Leung
- W.H. LoWLW.H. Lo
- S.M. TsuiSTS.M. Tsui
- K.C. LamKLK.C. Lam
- 1 June 2005
- journal article
- clinical trial
- Published by Elsevier in Cancer Letters
- Vol. 224 (1) , 67-80
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect of pegylation on pharmaceuticalsNature Reviews Drug Discovery, 2003
- Arginine catabolism, liver extracts and cancerPathology and Oncology Research, 2002
- PegylationClinical Pharmacokinetics, 2001
- Single amino acid (arginine) deprivation: rapid and selective death of cultured transformed and malignant cellsBritish Journal of Cancer, 2000
- Arginine metabolism: nitric oxide and beyondBiochemical Journal, 1998
- Arginine: Biochemistry, Physiology, and Therapeutic ImplicationsJournal of Parenteral and Enteral Nutrition, 1986
- The Effects of Arginine Deficiency on Lymphoma CellsBritish Journal of Cancer, 1974
- The Effect of Arginase on the Retardation of Tumour GrowthBritish Journal of Cancer, 1965
- Enzymes of Arginine Metabolism in Mammalian Cell CultureJournal of Biological Chemistry, 1964
- Inhibition of growth of cultured mammalian cells by liver extractsBiochimica et Biophysica Acta, 1960